Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generic vs Original PR-MPH in Children with ADHD
NCT05410626Unknown
- Sponsor
- Mahidol University
- Start
- Jun 2022
- Primary completion
- Aug 2022
- Modality
- Small Molecules
01
Overview
Randomised trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Mahidol University. Primary endpoint: Swanson, Nolan and Pelham version IV Parent Rating Scale at 8 weeks. Status: unknown.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT05410626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05410626.